Life Science Technology
Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA
| 4 min read
A small study shows that COVID-19 patients have wide-ranging immune responses to the viruses
| 3 min read
New library aims to accelerate the discovery of potent and urgently needed solutions
| 1 min read
Researchers hope to use antibodies from the animals to develop a treatment that would help people soon after infection with the virus
| 4 min read
PathogenDx combines RT-PCR and DNA microarray for greater specificity and multiplex capabilities
| 2 min read
Under the agreement, Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19
| 2 min read
Laboratory ramps up to full capacity of more than 10,000 tests per day with a 24-hour turnaround time
| 2 min read
Improved testing platforms with greater specificity, throughput, and environmental testing capabilities are essential to support public health decisions
| 3 min read
Bio-Rad's blood-based immunoassay test can help clinicians identify if an individual has developed antibodies against SARS-CoV-2, the virus associated with COVID-19
| 1 min read
Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership
| 2 min read
Researchers are studying ways to prevent β-amyloid peptides from forming these dangerous plaques in order to halt development of Alzheimer's disease in the brain
| 4 min read
Bio-Rad offers a portfolio of recombinant, monoclonal anti-idiotypic antibodies and drug-target complex binders for the development of highly selective and sensitive assays
| 2 min read
